Bacille Calmette-Guerin Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and sometimes other parts of the body, such as the bones, joints and kidneys.
The global Bacille Calmette-Guerin Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Bacille Calmette-Guerin Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Bacille Calmette-Guerin Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Bacille Calmette-Guerin Vaccine include Merck, Sanofi Pasteur, Japan BCG Lab, China National Biotec, Serum Institute of India, Intervax and GSBPL, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Bacille Calmette-Guerin Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bacille Calmette-Guerin Vaccine.
Report Scope
The Bacille Calmette-Guerin Vaccine market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Bacille Calmette-Guerin Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bacille Calmette-Guerin Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Sanofi Pasteur
Japan BCG Lab
China National Biotec
Serum Institute of India
Intervax
GSBPL
Segment by Type
Immune
Therapy
Segment by Application
Private Distribution Channel
Public Distribution Channel
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Bacille Calmette-Guerin Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Bacille Calmette-Guerin Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Bacille Calmette-Guerin Vaccine Market Overview
1.1 Product Overview and Scope of Bacille Calmette-Guerin Vaccine
1.2 Bacille Calmette-Guerin Vaccine Segment by Type
1.2.1 Global Bacille Calmette-Guerin Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Immune
1.2.3 Therapy
1.3 Bacille Calmette-Guerin Vaccine Segment by Application
1.3.1 Global Bacille Calmette-Guerin Vaccine Market Value by Application: (2024-2030)
1.3.2 Private Distribution Channel
1.3.3 Public Distribution Channel
1.4 Global Bacille Calmette-Guerin Vaccine Market Size Estimates and Forecasts
1.4.1 Global Bacille Calmette-Guerin Vaccine Revenue 2019-2030
1.4.2 Global Bacille Calmette-Guerin Vaccine Sales 2019-2030
1.4.3 Global Bacille Calmette-Guerin Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Bacille Calmette-Guerin Vaccine Market Competition by Manufacturers
2.1 Global Bacille Calmette-Guerin Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Bacille Calmette-Guerin Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Bacille Calmette-Guerin Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Bacille Calmette-Guerin Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Bacille Calmette-Guerin Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Bacille Calmette-Guerin Vaccine, Product Type & Application
2.7 Bacille Calmette-Guerin Vaccine Market Competitive Situation and Trends
2.7.1 Bacille Calmette-Guerin Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Bacille Calmette-Guerin Vaccine Players Market Share by Revenue
2.7.3 Global Bacille Calmette-Guerin Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Bacille Calmette-Guerin Vaccine Retrospective Market Scenario by Region
3.1 Global Bacille Calmette-Guerin Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Bacille Calmette-Guerin Vaccine Global Bacille Calmette-Guerin Vaccine Sales by Region: 2019-2030
3.2.1 Global Bacille Calmette-Guerin Vaccine Sales by Region: 2019-2024
3.2.2 Global Bacille Calmette-Guerin Vaccine Sales by Region: 2025-2030
3.3 Global Bacille Calmette-Guerin Vaccine Global Bacille Calmette-Guerin Vaccine Revenue by Region: 2019-2030
3.3.1 Global Bacille Calmette-Guerin Vaccine Revenue by Region: 2019-2024
3.3.2 Global Bacille Calmette-Guerin Vaccine Revenue by Region: 2025-2030
3.4 North America Bacille Calmette-Guerin Vaccine Market Facts & Figures by Country
3.4.1 North America Bacille Calmette-Guerin Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Bacille Calmette-Guerin Vaccine Sales by Country (2019-2030)
3.4.3 North America Bacille Calmette-Guerin Vaccine Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Bacille Calmette-Guerin Vaccine Market Facts & Figures by Country
3.5.1 Europe Bacille Calmette-Guerin Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Bacille Calmette-Guerin Vaccine Sales by Country (2019-2030)
3.5.3 Europe Bacille Calmette-Guerin Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Bacille Calmette-Guerin Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Bacille Calmette-Guerin Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Bacille Calmette-Guerin Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific Bacille Calmette-Guerin Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Bacille Calmette-Guerin Vaccine Market Facts & Figures by Country
3.7.1 Latin America Bacille Calmette-Guerin Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Bacille Calmette-Guerin Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Bacille Calmette-Guerin Vaccine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Bacille Calmette-Guerin Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Bacille Calmette-Guerin Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Bacille Calmette-Guerin Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Bacille Calmette-Guerin Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Bacille Calmette-Guerin Vaccine Sales by Type (2019-2030)
4.1.1 Global Bacille Calmette-Guerin Vaccine Sales by Type (2019-2024)
4.1.2 Global Bacille Calmette-Guerin Vaccine Sales by Type (2025-2030)
4.1.3 Global Bacille Calmette-Guerin Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Bacille Calmette-Guerin Vaccine Revenue by Type (2019-2030)
4.2.1 Global Bacille Calmette-Guerin Vaccine Revenue by Type (2019-2024)
4.2.2 Global Bacille Calmette-Guerin Vaccine Revenue by Type (2025-2030)
4.2.3 Global Bacille Calmette-Guerin Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Bacille Calmette-Guerin Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Bacille Calmette-Guerin Vaccine Sales by Application (2019-2030)
5.1.1 Global Bacille Calmette-Guerin Vaccine Sales by Application (2019-2024)
5.1.2 Global Bacille Calmette-Guerin Vaccine Sales by Application (2025-2030)
5.1.3 Global Bacille Calmette-Guerin Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Bacille Calmette-Guerin Vaccine Revenue by Application (2019-2030)
5.2.1 Global Bacille Calmette-Guerin Vaccine Revenue by Application (2019-2024)
5.2.2 Global Bacille Calmette-Guerin Vaccine Revenue by Application (2025-2030)
5.2.3 Global Bacille Calmette-Guerin Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Bacille Calmette-Guerin Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Bacille Calmette-Guerin Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck Bacille Calmette-Guerin Vaccine Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Sanofi Pasteur
6.2.1 Sanofi Pasteur Corporation Information
6.2.2 Sanofi Pasteur Description and Business Overview
6.2.3 Sanofi Pasteur Bacille Calmette-Guerin Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sanofi Pasteur Bacille Calmette-Guerin Vaccine Product Portfolio
6.2.5 Sanofi Pasteur Recent Developments/Updates
6.3 Japan BCG Lab
6.3.1 Japan BCG Lab Corporation Information
6.3.2 Japan BCG Lab Description and Business Overview
6.3.3 Japan BCG Lab Bacille Calmette-Guerin Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Japan BCG Lab Bacille Calmette-Guerin Vaccine Product Portfolio
6.3.5 Japan BCG Lab Recent Developments/Updates
6.4 China National Biotec
6.4.1 China National Biotec Corporation Information
6.4.2 China National Biotec Description and Business Overview
6.4.3 China National Biotec Bacille Calmette-Guerin Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 China National Biotec Bacille Calmette-Guerin Vaccine Product Portfolio
6.4.5 China National Biotec Recent Developments/Updates
6.5 Serum Institute of India
6.5.1 Serum Institute of India Corporation Information
6.5.2 Serum Institute of India Description and Business Overview
6.5.3 Serum Institute of India Bacille Calmette-Guerin Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Serum Institute of India Bacille Calmette-Guerin Vaccine Product Portfolio
6.5.5 Serum Institute of India Recent Developments/Updates
6.6 Intervax
6.6.1 Intervax Corporation Information
6.6.2 Intervax Description and Business Overview
6.6.3 Intervax Bacille Calmette-Guerin Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Intervax Bacille Calmette-Guerin Vaccine Product Portfolio
6.6.5 Intervax Recent Developments/Updates
6.7 GSBPL
6.6.1 GSBPL Corporation Information
6.6.2 GSBPL Description and Business Overview
6.6.3 GSBPL Bacille Calmette-Guerin Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 GSBPL Bacille Calmette-Guerin Vaccine Product Portfolio
6.7.5 GSBPL Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Bacille Calmette-Guerin Vaccine Industry Chain Analysis
7.2 Bacille Calmette-Guerin Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Bacille Calmette-Guerin Vaccine Production Mode & Process
7.4 Bacille Calmette-Guerin Vaccine Sales and Marketing
7.4.1 Bacille Calmette-Guerin Vaccine Sales Channels
7.4.2 Bacille Calmette-Guerin Vaccine Distributors
7.5 Bacille Calmette-Guerin Vaccine Customers
8 Bacille Calmette-Guerin Vaccine Market Dynamics
8.1 Bacille Calmette-Guerin Vaccine Industry Trends
8.2 Bacille Calmette-Guerin Vaccine Market Drivers
8.3 Bacille Calmette-Guerin Vaccine Market Challenges
8.4 Bacille Calmette-Guerin Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Merck
Sanofi Pasteur
Japan BCG Lab
China National Biotec
Serum Institute of India
Intervax
GSBPL
*If Applicable.